NEKTAR THERAPEUTICS
NKTR
17 insider filings · Latest: Sep 23, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Feb 18 8:15 PM | Zalevsky Jonathan | Proposed Sale | 180 | $73.00 | $13.1K | — | View → |
| Jan 20, 2026 | Jan 23 12:31 AM | Jonathan ZalevskyChief R&D Officer | Sale | 3,867 | $35.67 | $137.9K | 21,354(D) | View → |
| Jan 20, 2026 | Jan 20 9:21 PM | Zalevsky Jonathan | Proposed Sale | 3,867 | $35.67 | $137.9K | — | View → |
| Nov 25, 2025 | Nov 25 8:35 PM | ROBIN HOWARD W | Proposed Sale | 2,207 | $58.82 | $129.8K | — | View → |
| Nov 25, 2025 | Nov 25 8:32 PM | Wilson Mark Andrew | Proposed Sale | 630 | $58.82 | $37.1K | — | View → |
| Nov 25, 2025 | Nov 25 8:28 PM | Zalevsky Jonathan | Proposed Sale | 1,157 | $58.82 | $68.1K | — | View → |
| Sep 9, 2025 | Sep 9 8:57 PM | ROBIN HOWARD W | Proposed Sale | 6,666 | $46.69 | $311.2K | — | View → |
| Sep 5, 2025 | Sep 5 8:37 PM | ROBIN HOWARD W | Proposed Sale | 6,666 | $38.53 | $256.8K | — | View → |
| Sep 4, 2025 | Sep 4 9:06 PM | ROBIN HOWARD W | Proposed Sale | 5,166 | $33.70 | $174.1K | — | View → |
| Sep 4, 2025 | Sep 4 8:19 PM | Zalevsky Jonathan | Proposed Sale | 1,721 | $33.52 | $57.7K | — | View → |
| Sep 2, 2025 | Sep 2 8:45 PM | Zalevsky Jonathan | Proposed Sale | 485 | $30.10 | $14.6K | — | View → |
| Sep 2, 2025 | Sep 2 8:42 PM | ROBIN HOWARD W | Proposed Sale | 1,500 | $30.16 | $45.2K | — | View → |
| Aug 19, 2025 | Aug 19 7:24 PM | ROBIN HOWARD W | Proposed Sale | 1,573 | $26.59 | $41.8K | — | View → |
| Aug 19, 2025 | Aug 19 7:24 PM | Wilson Mark Andrew | Proposed Sale | 676 | $26.59 | $18.0K | — | View → |
| Aug 19, 2025 | Aug 19 7:20 PM | Zalevsky Jonathan | Proposed Sale | 725 | $26.59 | $19.3K | — | View → |
| May 19, 2025 | May 19 7:49 PM | Zalevsky Jonathan | Proposed Sale | 10,712 | $0.6713 | $7.2K | — | View → |
| May 19, 2025 | May 19 7:44 PM | Wilson Mark Andrew | Proposed Sale | 9,996 | $0.6713 | $6.7K | — | View → |
| May 19, 2025 | May 19 7:40 PM | ROBIN HOWARD W | Proposed Sale | 23,208 | $0.6713 | $15.6K | — | View → |
| Feb 19, 2025 | Feb 19 8:27 PM | Wilson Mark Andrew | Proposed Sale | 11,040 | $1.01 | $11.1K | — | View → |
| Feb 19, 2025 | Feb 19 8:21 PM | ROBIN HOWARD W | Proposed Sale | 23,774 | $1.01 | $24.0K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | Sep 26 12:29 AM | Roy A WhitfieldDirector | Grant/Award | 4,000 | $57.66 | 4,000(D) | View → |
| Sep 23, 2026 | Sep 26 12:26 AM | Scott R GreerDirector | Grant/Award | 4,000 | $57.66 | 4,000(D) | View → |
| Sep 23, 2026 | Sep 26 12:22 AM | Robert ChessDirector | Grant/Award | 4,000 | $57.66 | 4,000(D) | View → |
| Sep 23, 2026 | Sep 26 12:20 AM | Diana BrainardDirector | Grant/Award | 4,000 | $57.66 | 4,000(D) | View → |
| Sep 23, 2026 | Sep 26 12:18 AM | Jeffrey Robert AjerDirector | Grant/Award | 4,000 | $57.66 | 4,000(D) | View → |
| Jul 24, 2026 | Jul 24 10:35 PM | Jonathan ZalevskyChief R&D Officer | Grant/Award | 16,500 | $15.15 | 16,500(D) | View → |
| Jul 24, 2026 | Jul 24 10:34 PM | Howard W RobinDirector, President & CEO | Grant/Award | 57,200 | $15.15 | 57,200(D) | View → |